Home  »  Markets   »  Glaukos Corporation (GKOS) – Don’t Bel...

Glaukos Corporation (GKOS) – Don’t Believe the Hype: Check The Facts

287 institutions hold shares in Glaukos Corporation (GKOS), with 1.51M shares held by insiders accounting for 3.30% while institutional investors hold 113.03% of the company’s shares. The shares outstanding are 45.08M, and float is at 43.57M with Short Float at 10.05%. Institutions hold 109.30% of the Float.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Blackrock Inc. with over 6.99 million shares valued at $525.91 million. The investor’s holdings represent 15.14% of the GKOS Shares outstanding. As of Dec 30, 2020, the second largest holder is Brown Capital Management, Inc. with 6.51 million shares valued at $489.89 million to account for 14.10% of the shares outstanding. The other top investors are Baillie Gifford and Company which holds 4.86 million shares representing 10.54% and valued at over $366.1 million, while Vanguard Group, Inc. (The) holds 9.78% of the shares totaling 4.51 million with a market value of $339.65 million.

Glaukos Corporation (NYSE: GKOS) is 26.28% higher on its value in year-to-date trading and has touched a low of $34.10 and a high of $99.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GKOS stock was last observed hovering at around $97.70 in the last trading session, with the day’s loss setting it -2.66% off its average median price target of $89.50 for the next 12 months. It is also 14.38% off the consensus price target high of $111.00 offered by 12 analysts, but current levels are -98.0% lower than the price target low of $48.00 for the same period.

Currently trading at $95.04, the stock is 9.54% and 8.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing -2.72% at the moment leaves the stock 40.10% off its SMA200. GKOS registered 153.51% gain for a year compared to 6-month gain of 59.54%. The firm has a 50-day simple moving average (SMA 50) of $86.68 and a 200-day simple moving average (SMA200) of $78.13.

The stock witnessed a 12.50% loss in the last 1 month and extending the period to 3 months gives it a 4.85%, and is 3.59% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.41% over the week and 3.60% over the month.

Glaukos Corporation (GKOS) has around 653 employees, a market worth around $4.20B and $225.00M in sales. Profit margin for the company is -53.50%. Distance from 52-week low is 178.71% and -4.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.20%).

Glaukos Corporation (GKOS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Glaukos Corporation (GKOS) is a “Hold”. 12 analysts offering their recommendations for the stock have an average rating of 2.60, where 6 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

Glaukos Corporation is expected to release its quarterly report on 08/04/2021 and quarterly earnings per share for the current quarter are estimated at -$0.31 with sales reaching $65.07M over the same period.The EPS is expected to shrink by -821.50% this year, but quarterly earnings will post 30.20% year-over-year. Quarterly sales are estimated to grow 11.30% in year-over-year returns.

Glaukos Corporation (GKOS) Insider Activity

A total of 42 insider transactions have happened at Glaukos Corporation (GKOS) in the last six months, with sales accounting for 17 and purchases happening 25 times. The most recent transaction is an insider sale by Gilliam Joseph E, the company’s CFO, SVP Corporate Development. SEC filings show that Gilliam Joseph E sold 5,000 shares of the company’s common stock on Mar 15 at a price of $87.88 per share for a total of $0.44 million. Following the sale, the insider now owns 42802.0 shares.

Glaukos Corporation disclosed in a document filed with the SEC on Feb 09 that Gilliam Joseph E (CFO, SVP Corporate Development) sold a total of 13,750 shares of the company’s common stock. The trade occurred on Feb 09 and was made at $96.58 per share for $1.33 million. Following the transaction, the insider now directly holds 42802.0 shares of the GKOS stock.

Still, SEC filings show that on Feb 01, Calcaterra Chris M. (Chief Operating Officer) disposed off 60,417 shares at an average price of $88.38 for $5.34 million. The insider now directly holds 163,806 shares of Glaukos Corporation (GKOS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Glaukos Corporation (GKOS): Who are the competitors?

The company’s main competitors (and peers) include AtriCure Inc. (ATRC) that is trading 83.62% up over the past 12 months. Boston Scientific Corporation (BSX) is 17.82% up on the 1-year trading charts. Short interest in the company’s stock has fallen -1.86% from the last report on Apr 14, 2021 to stand at a total of 4.38 million short shares sold with a short interest ratio of 10.65.

Related Posts




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam